Legislation that would move billions of dollars into the research and development of new vaccines designed to offer protection from the avian flu and other pandemic threats is being blocked in Congress by a group representing trial lawyers. The American Trial Lawyers Association opposes language in the bill that would grant legal protections to companies involved in vaccine production. Article [1]
Links:
[1] http://www.washingtonpost.com/wp-dyn/content/article/2005/11/16/AR2005111602238.html